These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 277222)

  • 1. Enhancement of local tumour control by misonidazole and hyperthermia.
    Stone HB
    Br J Cancer Suppl; 1978 Jun; 3():178-83. PubMed ID: 277222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Radiosensitization of C3H/He mammary carcinoma by administration of hyperthermia and/or of misonidazole (author's transl)].
    Suyama S; Yabumoto E; Furunishi H; Kawanishi K; Yamazaki T; Abe M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1981; 41(10):998-1003. PubMed ID: 7335473
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of hypoxic radiosensitizer after mild hyperthermia in C3H mammary carcinoma.
    Ohizumi Y; Murayama C; Maezawa H; Mori T
    Tokai J Exp Clin Med; 1984 Oct; 9(4):331-7. PubMed ID: 6537042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of radioresponse of a mouse mammary carcinoma to combined treatments with hyperthermia and radiosensitizer misonidazole.
    Goldfeder A; Brown DM; Berger A
    Cancer Res; 1979 Aug; 39(8):2966-70. PubMed ID: 455281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumour-specific enhancement of thermoradiotherapy at mild temperatures by the vascular targeting agent 5,6-dimethylxanthenone-4-acetic acid.
    Murata R; Horsman MR
    Int J Hyperthermia; 2004 Jun; 20(4):393-404. PubMed ID: 15204520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of misonidazole and hyperthermia on the radiosensitivity of a C3H mouse mammary carcinoma and its surrounding normal tissue.
    Overgaard J
    Br J Cancer; 1980 Jan; 41(1):10-21. PubMed ID: 7362770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiosensitizing effect of combined radiotherapy, hyperthermia and misonidazole on C3H mouse FM3A tumor.
    Yamashita M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1984 Sep; 44(9):1181-8. PubMed ID: 6522270
    [No Abstract]   [Full Text] [Related]  

  • 8. Combined effects of misonidazole, microwave hyperthermia, and X-rays on the in vivo sister chromatid exchanges and chromosomal abnormalities of the dbrB tumor and on the survival of its host.
    Banerjee R; Goldfeder A; Mitra J
    Cancer Res; 1983 May; 43(5):2210-5. PubMed ID: 6831443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced local tumour control after single or fractionated radiation treatment using the hypoxic cell radiosensitizer doranidazole.
    Murata R; Tsujitani M; Horsman MR
    Radiother Oncol; 2008 Jun; 87(3):331-8. PubMed ID: 18375007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies in radiosensitizing effects of misonidazole and SR-2508 on C3H/He mouse mammary tumors.
    Ono K; Takahashi M; Nishidai T; Dodo Y; Shibamoto Y; Hiraoka M; Yukawa Y; Abe M
    Radiat Med; 1984; 2(1):71-5. PubMed ID: 6242712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of magnetic fluid hyperthermia (MFH) on C3H mammary carcinoma in vivo.
    Jordan A; Scholz R; Wust P; Fähling H; Krause J; Wlodarczyk W; Sander B; Vogl T; Felix R
    Int J Hyperthermia; 1997; 13(6):587-605. PubMed ID: 9421741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of hyperthermia and cis-diamminedichloroplatinum(II) alone or combined with radiation in a C3H mammary carcinoma in vivo.
    Overgaard J; Radacic MM; Grau C
    Cancer Res; 1991 Jan; 51(2):707-11. PubMed ID: 1985787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxicity of radiosensitizers in multicell spheroids: combination treatment with hyperthermia.
    Sutherland R; Macfarlane W
    Br J Cancer Suppl; 1978 Jun; 3():168-72. PubMed ID: 277220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of hyperthermia and the hypoxic cell sensitizer Ro-07-0582 on the EMT6 mouse tumour.
    Bleehen NM; Honess DJ; Morgan JE
    Br J Cancer; 1977 Mar; 35(3):299-306. PubMed ID: 856237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxygen cathode measurements and radiation response in tumour-bearing mice treated with misonidazole.
    Davies RW; Hall WS
    Br J Cancer Suppl; 1978 Jun; 3():154-8. PubMed ID: 277216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo cytotoxicity of misonidazole and hyperthermia in a transplanted mouse mammary tumor.
    Lehman CM; Stewart JR
    Radiat Res; 1983 Dec; 96(3):628-34. PubMed ID: 6657927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Radiosensitizing effect of the nitroimidazole derivatives RK28 and DNIE on murine tumors].
    Tanaka M; Fukuda H; Nakajima T; Sugimoto K; Onoyama Y; Hori H; Inayama S
    Nihon Igaku Hoshasen Gakkai Zasshi; 1988 Oct; 48(10):1249-60. PubMed ID: 3222139
    [No Abstract]   [Full Text] [Related]  

  • 18. Selective enhancement of the cytotoxicity of the bleomycin derivative, peplomycin, by local anesthetics alone and combined with hyperthermia.
    Mizuno S; Ishida A
    Cancer Res; 1982 Nov; 42(11):4726-9. PubMed ID: 6181868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of nitro-L-arginine on blood flow, oxygenation and the activity of hypoxic cell cytotoxins in murine tumours.
    Horsman MR; Chaplin DJ; Hill SA; Arnold S; Collingridge D; Radacic M; Wood PJ; Overgaard J
    Br J Cancer Suppl; 1996 Jul; 27():S168-71. PubMed ID: 8763873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The demonstration of in vivo misonidazole tumour toxicity using post radiation hypoxia.
    Gomer CJ; Johnson RJ; Hetzel FW; Lawrence G
    Br J Cancer Suppl; 1978 Jun; 3():228-31. PubMed ID: 277234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.